DRREDDY — Dr Reddy's Laboratories Income Statement
0.000.00%
Last trade - 00:00
- IN₹1.04tn
- IN₹981.87bn
- IN₹246.70bn
- 98
- 27
- 98
- 91
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 154,482 | 175,170 | 190,475 | 215,452 | 246,697 |
Cost of Revenue | |||||
Gross Profit | 104,686 | 115,044 | 124,828 | 135,480 | 163,649 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 134,048 | 162,030 | 164,022 | 189,427 | 194,498 |
Operating Profit | 20,434 | 13,140 | 26,453 | 26,025 | 52,199 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 22,920 | 18,857 | 28,835 | 30,614 | 60,485 |
Provision for Income Taxes | |||||
Net Income After Taxes | 19,065 | 20,219 | 19,203 | 21,781 | 45,073 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 19,500 | 20,260 | 19,516 | 21,825 | 45,073 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 19,500 | 20,260 | 19,516 | 21,825 | 45,073 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 112 | 188 | 143 | 166 | 279 |
Dividends per Share |